Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1974 1
1976 1
1978 1
1981 2
1982 3
1983 2
1984 3
1985 1
1986 1
1987 1
1991 2
1992 1
1993 1
1994 2
1995 1
1996 3
1997 3
1998 3
1999 3
2000 3
2001 2
2002 3
2003 4
2004 3
2005 6
2006 3
2007 5
2008 6
2009 3
2010 6
2011 6
2012 3
2013 6
2014 11
2015 5
2016 5
2017 8
2018 10
2019 7
2020 7
2021 2
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Ewing sarcoma and Ewing-like tumors.
Sbaraglia M, Righi A, Gambarotti M, Dei Tos AP. Sbaraglia M, et al. Virchows Arch. 2020 Jan;476(1):109-119. doi: 10.1007/s00428-019-02720-8. Epub 2019 Dec 4. Virchows Arch. 2020. PMID: 31802230 Review.
Interestingly, despite significant morphologic overlap, most of these entities tend to exhibit morphologic features predictive of the underlying molecular alteration. Ewing sarcoma is the prototype of round cell sarcoma whereas in CIC sarcomas, focal pleomorphism and epith …
Interestingly, despite significant morphologic overlap, most of these entities tend to exhibit morphologic features predictive of the …
Chondrosarcoma.
Weinschenk RC, Wang WL, Lewis VO. Weinschenk RC, et al. J Am Acad Orthop Surg. 2021 Jul 1;29(13):553-562. doi: 10.5435/JAAOS-D-20-01188. J Am Acad Orthop Surg. 2021. PMID: 33595238
Symptoms are often characterized by focal, dull, aching pain to the affected region. Grade is a well-recognized prognostic factor in these tumors. Grade I lesions/atypical cartilaginous tumors rarely metastasize, rarely recur, and have a 10-year survival rate of >80%. B …
Symptoms are often characterized by focal, dull, aching pain to the affected region. Grade is a well-recognized prognostic factor in …
Extraskeletal Mesenchymal Chondrosarcoma.
Arora K, Riddle ND. Arora K, et al. Arch Pathol Lab Med. 2018 Nov;142(11):1421-1424. doi: 10.5858/arpa.2017-0109-RS. Arch Pathol Lab Med. 2018. PMID: 30407856 Free article. Review.
It can pose a diagnostic challenge in small biopsy specimens where 1 of the 2 components can be absent. The prognosis is extremely variable; survival varies depending on the location of the tumor....
It can pose a diagnostic challenge in small biopsy specimens where 1 of the 2 components can be absent. The prognosis is extremely va …
Bone Pathology for Hematopathologists.
Peker D, Wei S, Siegal GP. Peker D, et al. Surg Pathol Clin. 2019 Sep;12(3):831-847. doi: 10.1016/j.path.2019.03.007. Epub 2019 May 22. Surg Pathol Clin. 2019. PMID: 31352990 Review.
Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options.
Tlemsani C, Larousserie F, De Percin S, Audard V, Hadjadj D, Chen J, Biau D, Anract P, Terris B, Goldwasser F, Pasmant E, Boudou-Rouquette P. Tlemsani C, et al. Int J Mol Sci. 2023 Jan 10;24(2):1361. doi: 10.3390/ijms24021361. Int J Mol Sci. 2023. PMID: 36674874 Free PMC article. Review.
Chemotherapy is possibly effective in mesenchymal chondrosarcoma and is of uncertain value in dedifferentiated chondrosarcoma. Due to resistance to standard anticancer agents, the prognosis is poor in patients with metastatic or unresectable chondrosarcomas. ...
Chemotherapy is possibly effective in mesenchymal chondrosarcoma and is of uncertain value in dedifferentiated chondrosarcoma. Due to resist …
Mesenchymal chondrosarcoma: An Australian multi-centre cohort study.
Strach MC, Grimison PS, Hong A, Boyle R, Stalley P, Karim R, Connolly EA, Bae S, Desai J, Crowe P, Singhal N, Bhadri VA. Strach MC, et al. Cancer Med. 2023 Jan;12(1):368-378. doi: 10.1002/cam4.4849. Epub 2022 May 23. Cancer Med. 2023. PMID: 35603739 Free PMC article.
BACKGROUND: Mesenchymal chondrosarcoma (MCS) is an ultra-rare sarcoma that follows a more aggressive course than conventional chondrosarcoma. This study evaluates prognostic factors, treatments (surgery, chemotherapy, and radiation), and outcomes in an Australian se …
BACKGROUND: Mesenchymal chondrosarcoma (MCS) is an ultra-rare sarcoma that follows a more aggressive course than conventional chondro …
The clinical approach towards chondrosarcoma.
Gelderblom H, Hogendoorn PC, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AH, Bovée JV. Gelderblom H, et al. Oncologist. 2008 Mar;13(3):320-9. doi: 10.1634/theoncologist.2007-0237. Oncologist. 2008. PMID: 18378543 Free article. Review.
Conventional chondrosarcomas can be categorized according to their location in bone into central, peripheral, and juxtacortical chondrosarcomas. Histological grading is related to prognosis; however, it is also subject to interobserver variability. ...
Conventional chondrosarcomas can be categorized according to their location in bone into central, peripheral, and juxtacortical chondrosarco …
Primary Spinal Intradural Extramedullary Mesenchymal Chondrosarcoma.
Saito R, Senbokuya N, Yagi T, Yoshioka H, Kanemaru K, Kinouchi H. Saito R, et al. World Neurosurg. 2021 Jan;145:376-380. doi: 10.1016/j.wneu.2020.10.007. Epub 2020 Oct 10. World Neurosurg. 2021. PMID: 33049384
CONCLUSIONS: Primary spinal intradural extramedullary MCS has been reported to have a better prognosis than MCS occurring in other regions. In a case with early complete surgical resection, adjuvant therapy should be considered at the time of recurrence....
CONCLUSIONS: Primary spinal intradural extramedullary MCS has been reported to have a better prognosis than MCS occurring in other re …
Mesenchymal chondrosarcoma: a clinicopathologic and flow cytometric study of 13 cases presenting in the central nervous system.
Rushing EJ, Armonda RA, Ansari Q, Mena H. Rushing EJ, et al. Cancer. 1996 May 1;77(9):1884-91. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1884::AID-CNCR19>3.0.CO;2-W. Cancer. 1996. PMID: 8646689 Review.
Morphologic features have not been found to correlate reliably with prognosis. METHODS: Eight intracranial and five intraspinal mesenchymal chondrosarcomas were reviewed with regard to location, treatment, and long term follow-up data. ...CONCLUSIONS: Review of the literat …
Morphologic features have not been found to correlate reliably with prognosis. METHODS: Eight intracranial and five intraspinal mesen …
141 results